Ministry of Health and Family Welfare Current Affairs - 2019

Category Wise PDF Compilations available at This Link

India hosts Global Digital Health Partnership Summit

The 4th Global Digital Health Partnership Summit being held at New Delhi was inaugurated by the Union Health Minister J P Nadda in the presence of Shri Ravi Shankar Prasad Union Minister of Law & Justice and Electronics & Information Technology.

The summit provides an opportunity to support governments and health system reformers in improving the health and well-being of their citizens through digital technologies.

The Global Digital Health Partnership Summit is being hosted by the Ministry of Health and Family Welfare in collaboration with the World Health Organization (WHO) and the Global Digital Health Partnership (GDHP).

Global Digital Health Partnership

The Global Digital Health Partnership (GDHP) is a collaboration of governments and territories, government agencies and the World Health Organization aimed at supporting the effective implementation of digital health services.

The GDHP was established in February 2018 to provide an international platform for global collaboration and sharing of evidence to guide the delivery of better digital health services within participant countries.

The GDHP also provides an opportunity for transformational engagement between its participants, who are striving to learn and share best practice and policy that can support their digital health systems.

The secretariat services for the GDHP are provided by  Australian Digital Health Agency for the initial 18 months.

Month: Categories: InternationalUPSC

Tags:

Government notifies four commonly used medical devices as drugs

Union Ministry of Health & Family Welfare has notified four medical devices including blood pressure monitors, nebulisers, digital thermometers and glucometers as drugs under Drugs and Cosmetics Act, 1940. The decision will enable the government to ensure their quality and performance. Drug Controller General of India (DCGI) will regulate import, manufacture and sale of these devices from January 2020.

Key Facts

Companies which are engaged in manufacture and import of these equipment will have to seek necessary permission or license from DCGI from January 1, 2020 onward. All these devices will have to be registered under quality parameters prescribed under Medical Devices Rules, 2017 and other standards set by Bureau of Indian Standard (BIS) certification.

With addition of these four new devices, the number of medical devices falling under definition of drugs under this law goes up to 27. Prior to this, only 23 medical devices were monitored for quality by DCGI. The other medical equipments are sold without any quality checks or clinical trials. Drug Technical Advisory Body (DTAB), the country’s highest drug advisory body earlier had approved the proposal to include these four medical devices under purview of Drug law.

Background

Union Health Ministry has proposed expanding list of medical devices in eight new categories under definition of ‘drugs’ to bring them under purview of Drugs and Cosmetics Act, 1940. The eight categories include implantable medical devices, CT scan equipment, MRI equipment, defibrillators, implants, PET equipment, dialysis machines, X-ray machines and bone marrow cell separator.

Drugs Controller General of India (DCGI)

DCGI under gamut of Central Drugs Standard Control Organization (CDSCO) is responsible for approval of licenses of specified categories of drugs such as blood and blood products, vaccines, IV fluids and sera in India. DCGI lays down standards and quality of manufacturing, selling, import and distribution of drugs in India. It acts as appellate authority in case of any dispute regarding quality of drugs. It prepares and maintains national reference standard. It brings about uniformity in enforcement of Drugs and Cosmetics Act. It trains Drug Analysts deputed by State Drug Control Laboratories and other Institutions.

Month: Categories: National

Tags: